Investigation of colon-specific dosage forms of ondansetron prepared with natural polymers

Pharmazie

Volumn 61, Issue 11, 2006, Pages 916-919

  Tugcu Demiroz F ^a   Acarturk F ^a   Takka, S ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; GUAR GUM; ONDANSETRON; POLYMER;

ARTICLE; COLON; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG RELEASE; IN VITRO STUDY; IRRITABLE COLON; MOTOR ACTIVITY; SMALL INTESTINE; TABLET; TABLET COMPRESSION; VISCERA;

ALGINATES; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; COLON; DRUG DELIVERY SYSTEMS; EXCIPIENTS; GALACTANS; MANNANS; ONDANSETRON; PLANT GUMS; POLYMERS; SEROTONIN ANTAGONISTS;

EID: 33751332989     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ashford M, Fell JT, Attwood D, Sharma H, Woodhead PJ (1993) An in vivo investigation into the suitability of pH dependent polymers for colonic targeting. Int J Pharm 95: 193-199.
2. Bajaj A, Sawarkar S, Deshpande S, Soni P, Pandit P (2001) In vivo-in vitro evaluation of natural polymer guar gum as carrier for drug targeting to the colon. Proceed Int Symp Rel Control Rel Bioact Mater 28: 6043.
3. 2+ ions. Reac Func Poly 59: 129-140.
4. Farthing MJ (1999) Irritable bowel syndrome: new pharmaceutical approches to treatment. Baillieres Best Pract Res Clin Gastroenterol 13: 461-471.
5. Farthing MJ (2004) Treatment options in irritable bowel syndrome. Best Practice & Res Clin Gastroenterol 18: 773-786.
6. Friend DR (2005) New oral delivery systems for treatment of inflammatory bowel disease. Adv Drug Del Rev 57: 247-265.
7. Goldberg PA, Kamm MA, Setti-Carraro P, Vander SIJP, Roth C (1996) Modification of visceral sensitivitiy and pain in irritable bowel syndrome by 5-HT3 antagonism (ondansetron). Digestion 57: 478-483.
8. Holte Ø, Onsøyen E, Myrvold R, Karlsen J (2003) Sustained release of water-soluble drug from directly compressed alginate tablets. Eur J Pharm Sci 20: 403-407.
9. Hsyu P, Pritchard JF, Bozigian HP, Lloyd TL, Griffin RH, Shamburek R, Krishna G, Barr WH (1994) Comparison of the pharmacokinetics of an ondansetron solution (8 mg) when administered intravenously, orally, to the colon, and to the rectum. Pharm Res 11: 156-159.
10. Iruin A, Fernandez-Arevalo M, Alvarez-Fuentes J, Fini A, Holgado MA (2005) Elaboration and in vitro characterization of 5-ASA beads. Drug Dev Ind Pharm 31: 231-239.
11. Krishnaiah YSR, Veer Raju P, Dinesh Kumar B, Bhaskar P, Satyanarayana V (2001) Development of colon targeted drug delivery systems for mebendazole. J Control Rel 77: 87-95.
12. Lamers CBHW (1991) Ondansetron: effects on gastrointestinal motility. Scand J Gastroenterol Suppl 188: 124-126.
13. Lin Y-H, Liang H-F, Chung C-K, Chen M-C, Sung H-W (2005) Physically crosslinked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs. Biomaterials 26:2105-2113.
14. Ofori-Kwakye K, Fell JT (2003) Biphasic drug release from film-coated tablets. Int J Pharm 250: 431-440.
15. Prasad YVR, Krishnaiah YSR, Satyanatyana S (1998) In vitro evaluation of gur gum as a carrier for colon-specific drug delivery. J Control Release 51: 281-287.
16. Rodriguez M, Vila-Jato JL, Torres D (1998) Desing of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J Control Release 55: 67-77.
17. Rothstein RD (2000) Irritable Bowel Syndrome. Med Clin North America 84: 5.
18. Sinha VR, Mittal BR, Kumria R (2005) In vivo evaluation of time and side of disintegration of polysaccharide tablet prepared for colon-specific drug delivery. Int J Pharm 289: 79-85.
19. Talley NJ, Phillips SF, Haddad A, Miller LJ, Twomey C, Zinsmeister AR, MacCarty RL, Ciociola A (1990) GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci 35: 477-80.
20. Takka S, Acartürk F (1999) Calcium alginate microparticles for oral administration: I-Effect of sodium alginate type on drug release and drug entrapment efficiency. J Microencapsul 16: 275-290.
21. Tugcu-Demiröz F, Acartürk F, Takka S, Konuş- Boyunaǧa ÖL (2004) In vitro and in vivo evaluation of mesalazine-guar gum matrix tablets for colonic drug delivery. J Drug Target 12:105-112.
22. Türkoǧlu M, Uǧurlu T (2002) In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery. Eur J Pharm Biopharm 53: 65-73.
23. Vandamme TF, Lenourry A, Charrueau C, Chaumeil J-C (2002) The use of polysaccharides to target drugs to the colon, Carbohydrat Poly 48: 219-231.
24. Wong D, Larrabee S, Clifford K, Tremblay J, Friend D (1997) USP dissolution apparatus DJ (reciprocating cylinder) for screening of guar-based colonic delivery formulations. J Control Release 47: 173-179.
25. Xing L, Dawei C, Liping X, Rongqing Z (2003) Oral colon-specific drug delivery for bee venom peptide: development of a coated calcium alginate gel beads-entrapped liposome. J Control Release 93: 293-300.
26. Yokoe J, Iwasaki N, Haruta S, Kadono K, Ogawara K, Higaki K, Kimura T (2003) Analysis and prediction of absorption behavior of colon-targeted prodrug in rats by GI-transit-absorption model. J Cotrol Release 86: 305-313.